Peripheral blood mononuclear cells (PBMCs) were isolated from fresh buffy coats (provided by the National Blood Transfusion Service, Birmingham, U.K) using Ficollpaque density centrifugation. CD4 + T cells were isolated by incubating PBMC with human CD4 + T cell-enrichment cocktail and magnetic colloid according to the manufacture's instruction (Stem Cell Technologies, France). To purify CD25 + T cells CD4 + cells were incubated with anti-CD25-microbeads (Miltenyi Biotech, Auburn, CA) at 4 o C for 30 minutes. CD4 + CD25 -T cells which did not bind to the column, were collected from the flow-through and washed before use. CD4 + CD25 + T cells were subsequently retrieved from the column. Human monocytes were purified from PBMC by negative selection using human monocyte enrichment mixture and magnetic colloid according to the instructions of the manufacturer (Stem Cell Technologies, France). To generate dendritic cells (DCs), monocytes (2 x 10 6 cells/ml) were cultured in RPMI 1640 medium containing 10% FCS and antibiotics with GM-CSF (PeproTech, Rocky Hill, NJ; 800 U/ml) and IL-4 (PeproTech; 500 U/ml). Additional medium containing GM-CSF and IL-4 was added every 2 days. To generate SEB-specific T cell blasts PBMCs were incubated with 1µg/ml SEB for 6 days. Live CD4 + cells were then negatively purified as above. Where stated DCs were re-isolated from T cell cultures using anti-CD2 microbeads (Miltenyi) to deplete T cells.
CD86 transfer into CTLA-4 expressing cells was carried out by labeling CD86 GFP expressing CHO cells with CellTrace Far Red DDAO-SE (Invitrogen). Cells were then incubated together with CTLA-4 expressing CHO cells for 3 hours in the presence or absence of 10 nM Bafilomycin A or 10 µM NH 4 Cl. To identify GFP transfer to single, CTLA-4 expressing cells and exclude clusters containing CD86-GFP, cells were gated for low pulse width and negative for Far Red staining as shown in Supplementary figure S1. CD80 GFP transfer was assayed in a similar way. Where used, PKH 26 (Sigma) labeling was carried out by incubating CHO-CD86 cells according to manufacturer's instructions.
CFSE dilution
For assessing T cell proliferation, responder CD4 + CD25 -T cells were labeled using 5-(and-6)-carboxyfluorescein diacetate, succinimidyl ester (CFSE, Molecular Probes). CD4+ CD25-T cells were washed twice in PBS and resuspended at 2 x 10 7 cells/ml and an equal volume of CFSE in PBS added such that the final concentration was 2.5 µM.
Cells were then incubated at RT for 10 minutes with gentle agitation and washed twice in normal growth medium. When stimulating with CD86 transfectants, CHO cells were fixed using 0.025% glutaraldehyde in PBS for 2-3 min and washed extensively. Fixed CHO cells and CFSE labeled responder cells with then incubated (1 CHO cell : 5 T cells unless otherwise specified) with anti-CD3 (0.5µg/ml) for 5 days before analysis by flow cytometry. When using Jurkat cells as suppressors, cells were incubated overnight with CHO cells and Jurkat cells removed using anti-CD2 microbeads (Miltenyi) prior to fixation. When using dendritic cells as stimulators, cells were cultured with CD4 + CD25 + purified Tregs for 5 days with 0.5 µg/ml anti-CD3 (+/-anti-CTLA-4 20 µg/ml). DC were re-isolated by depleting CD2 positive cells with anti-CD2 microbeads (Miltenyi Biotech).
Where indicated T cell blasts were used as CTLA4+ suppressor cells. Blasts were generated by CD3/CD28 bead stimulation for 5 days and added to along with CFSElabelled responder T cells. Cells were stimulated with DC and anti-CD3(0.5µg/ml) for 5 days in the presence or absence of anti-CTLA-4 (20 µg/ml) before analysis by flow cytometry.
CD86 surface downregulation
For surface analysis of DC phenotypes, cells were collected into cold PBS and surface labeled at 4°C with antibodies against CD86, CD80, CD40 or CD11c directly conjugated to FITC, PE or APC (BD PharMingen, San Diego, CA). DCs were gated based on forward and side scatter, and CD11c labeling. DCs were incubated with T cells at the ratios indicated.
CTLA-4 Antibodies
Surface staining of CTLA-4 was carried out on ice for 30 min. Staining of cycling CTLA-4 was carried out by incubation at 37°C for 30min. Total CTLA-4 staining was carried out by fixing cells with 3.0% formaldehyde solution in PBS and permeabilizing with 0.1% saponin and then staining with anti-CTLA-4 PE (BNI3-Pharmingen) or anti-CTLA-4 C-19 antibody (Santa Cruz) followed by an appropriate secondary antibody.
Where stated T cells were stimulated using anti-CD3 anti-CD28 beads (Invitrogen) for 2h prior to staining. To study CTLA-4 cycling in Treg, cells were incubated overnight with anti-CD3 anti-CD28 beads and CTLA-4 staining carried out at 37 o C. Where blocking anti-CTLA-4 was used unconjugated anti-CTLA-4 was used at 20µg/ml. FOXP3 staining was performed using a FOXP3 staining kit (Ebioscience) according to the manufacturer's instructions.
Estimation of molecules of CD86 and CTLA-4
We used Quantum Simply Cellular anti-mouse IgG beads (Bangs Laboratories Inc, IN) according to the manufacturers instructions. Briefly, calibration curves were produced by titrating antibodies with beads of known antigen binding capacity. Flow cytometric staining of cells was then carried out using saturating titrations of antibody and used to estimate number of molecules from the calibration curves.
Confocal microscopy
Imaging was carried out using a Zeiss LSM 510 or a Zeiss LSM 780 inverted laser scanning confocal microscope using a 100x oil immersion objective with excitation at 488nm, 543nm and 633nm. Constant laser powers and acquisition parameters were maintained throughout individual experiments for analysis. Digital images were prepared using ImageJ (Wayne Rasband, NIH). For quantitation, cells were outlined and mean fluorescence intensity measured using ImageJ. Movies were prepared using ImageJ. All confocal images shown are representative of at least thirty micrographs taken from at least three independent experiments.
Live Cell Imaging
Cells were imaged using glass bottom culture dishes (MatTek). In single time point experiments CTLA-4 expressing cells were labelled with DDAO-SE and incubated with CD86-GFP CHO cells for 3h. For time course experiments CTLA-4 expressing CHO cells were identified by brief labeling with anti-CTLA-4 APC (BD) and incubated with CHO cells stably expressing CD86-GFP. Z-stacks were acquired as a time-series aproximately every 3 minutes for 90 minutes (Movie S1) or every 1 minute (Movie S2-4). Projections were then generated using ImageJ and converted into movies or single images. Movie S2 contains a single confocal plane.
Immunofluorescence staining
For co-localisation of CD86 and CTLA-4, CHO cells, were incubated together for 16 hours on a poly-L-lysine coated coverslip in a 24 well plate. Cells were then fixed with methanol at -20°C for 20 minutes. Non-specific binding sites were blocked by incubation in blocking solution (BS) which consisted of 5% donkey serum (Sigma) in PBS at room temperature (RT). Cells were incubated with anti-CD86 primary antibody (B7-2, C19 antibody, Santa Cruz, CA) and anti-CTLA-4 (BNI3 Pharmingen), washed and then labeled with donkey anti-goat Alexa 546 and anti-mouse Alexa 488 secondary antibodies (Molecular Probes).
Dendritic cells and T cells were added at a 1:3 ratio to poly-L-lysine coated coverslips in a 24 well plate. Cells were activated by the addition of anti-CD3 (Clone OKT3) at a concentration of 1 µg/ml and were incubated for 72h (CD4 + CD25 -) or overnight (CD4+CD25+) at 37 °C and 5 % CO 2 . Where SEB stimulation was used , DC were pulsed with 1µg/ml SEB for 2h and washed prior to use. Cells were centrifuged in a swing out rotor at 200 g for 10 minutes and fixed with methanol at -20°C for 20 minutes.
Non-specific binding sites were blocked by incubation in blocking solution (BS). Cells were incubated with anti-CD86 primary antibody (B7-2, C19 antibody, Santa Cruz, CA), 
Electron Microscopy
Cryo-immuno-EM was performed on cells fixed with 4% paraformaldehyde in 0.1M phosphate buffer pH 7.4, supported in 10% gelatin, and infused with 2.3M sucrose.
Sections (70 nm) were cut at -120°C and picked up in 1:1 2.3M sucrose:2% methylcellulose. Mouse anti-HA ( HA.11, Covance) was followed by rabbit anti-mouse intermediate antibody (Dako) and 10nm protein A gold and then contrast stained/dried in 1:9 4% uranyl acetate:2% methyl cellulose. Samples were viewed on a JEOL 1010 TEM, and images gathered with a Gatan OriusSC100B CCD camera. Restimulate with 100µg OVA peptide intravenously for 6h in the presence of chloroquine (to inhibit lysosomal degradation) for final 3h.
Supplementary Figure Legends
Harvest splenocytes and analyse immediately by confocal microscopy. 
In vivo trans-endocytosis work flow

